From billing frequency to transmission requirements, the following details clarify when and how this new RPM code can be used: Code (finalized): CPT 99445 (was previously known as 99XX4) Status: Included in CMS's 2026 Physician Fee Schedule final rule Description: Covers the supply of an FDA-cleared device and the collection/transmission of physiological data on 215 days within a 30-day period Billing frequency: Once every 30 days per patient Data transmission requirement: Must receive at least 2 but fewer than 16 days of data Who Can Bill for CPT 99445
Hypophosphatemia (Low Phosphate) Diuretics (loop, thiazide): renal phosphate loss Antacids (aluminum hydroxide): Bind phosphate absorption Insulin therapy: Drives phosphate into cells serum phosphate High-Yield Exam Points Loop diuretics: K, Mg, Ca Thiazides: K, Ca Potassium-sparing diuretics / ACEi / ARBs: K NSAIDs: mild K, Na Corticosteroids: Na, K Mnemonic for Diuretic Electrolyte Effects: Loop: Low K, Mg, Ca
Not only is there rising social popularity of the drug, Petrou said, but theres also wider FDA indications for use. Semaglutide was patented by the Danish pharmaceutical company Novo Nordisk in 2012 and has been available in the United States since the FDA approved it in 2017
Travel and Storage Best Practices for Tirzepatide Patients Traveling with tirzepatide requires planning ahead
Reach out to a trusted provider to explore how Tirzepatide can fit into your weight loss goals
Recent real-world research, including studies presented at the European Congress on Obesity, suggests that a slow taper off Wegovy combined with behavioral coaching can help maintain weight loss after medication cessation